Abstract 2199: Establishment and high-throughput drug testing of multiple patient-derived cells from each renal cancer; intratumor heterogeneity of drug response and implications for precision medicine

JSON

Saeed K, Ojamies P, Pellinen T, Eldfors S, Turkki R, Lundin J, Nisen H, Järvinen P, Taari K, Hällström Ta, Rannikko A, Mirtti T, Kallioniemi O, Östling P

Cancer Res. 78 (13_Supplement) 2199-2199 [2018-07-01; online 2018-07-01]

DOI 10.1158/1538-7445.am2018-2199

Crossref 10.1158/1538-7445.am2018-2199